臺灣結核病實作指引, published by 衛福部疾病管制署. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/omnifhir/tb/ and changes regularly. See the Directory of published versions
Profile: 二線藥敏-Observation Drug Sensitive 2
status:Final
category:Laboratory
code:二線藥敏報告
subject:Patient/example
二線藥敏報告日期(effective):2026-03-16 10:45:00+0800
送驗單位(performer):Organization/hosp
分子檢測工具(method):Genotype MTBDRsl
component
code:二線藥敏-高濃度Kanamycin
value:敏感
component
code:二線藥敏-低濃度Kanamycin
value:敏感
component
code:二線藥敏-Ofloxacin
value:敏感
component
code:二線藥敏-Ethionamide
value:敏感
component
code:二線藥敏-p-aminosalicylicacid
value:敏感
component
code:二線藥敏-Rifabutin
value:敏感
component
code:二線藥敏-Capreomycin
value:敏感
component
code:二線藥敏-Ciprofloxacin
value:敏感
component
code:二線藥敏-Moxifloxacin
value:敏感
component
code:二線藥敏-Gatifloxacin
value:敏感
component
code:二線藥敏-Levofloxacin
value:敏感
component
code:二線藥敏-Amikacin
value:敏感
component
code:二線藥敏-Prothionamide
value:敏感
component
code:二線藥敏-Cycloserine
value:敏感
component
code:二線藥敏-Terizidone
value:敏感
component
code:二線藥敏-Thioacetazone
value:敏感
component
code:二線藥敏-Enviomycin
value:敏感
component
code:其他二線藥敏
value:敏感
二線藥敏備註(note):二線藥敏備註